Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Spencer R. Haupert
Observed names:
S. Haupert,
Spencer Haupert,
Spencer R Haupert
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
University of Michigan
ORCID:
0000-0001-5959-2301
Observed ORCID:
0000-0001-5959-2301
OpenAlex ID:
A5067833063
Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review
2022
·
Chen Chen
, Spencer R Haupert
, et al.
·
The Journal of Infectious Diseases
·
1,612
PDF
A Case-Crossover Phenome-wide association study (PheWAS) for understanding Post-COVID-19 diagnosis patterns
2022
·
Spencer R. Haupert
, Xu Shi
, et al.
·
Journal of Biomedical Informatics
·
10
PDF
US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia
2025
·
Nina Kim
, E. Dianne Pulte
, et al.
·
Journal of Clinical Oncology
·
9
Methodological and regulatory considerations for causal AI in drug development
2026
·
Hana Lee
, Sky Qiu
, et al.
·
npj Digital Medicine
·
6
PDF
4-twist helix snake to maintain polarization in multi-GeV proton rings
2017
·
F. Antoulinakis
, Y. Chen
, et al.
·
Physical Review Accelerators and Beams
·
5
PDF
Targeted maximum likelihood estimation (TMLE) in regulatory submissions and research: a landscape analysis
2026
·
Hana Lee
, Menglun Wang
, et al.
·
The International Journal of Biostatistics
·
1
Show more works
View as search
Works count:
6
Citation count:
1,643
H-index:
5
I10-index:
2
Year
Topic
Type